Literature DB >> 6749689

Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice.

J R Wingard, J D Dick, W G Merz, G R Sandford, R Saral, W H Burns.   

Abstract

Prior reports from this institution indicated that Candida tropicalis was more pathogenic than C. albicans in oncology patients. Pairs of clinical isolates of C. tropicalis and C. albicans recovered from similar patients at other institutions were examined to determine their relative virulence. After intravenous inoculation in normal mice, three pairs of isolates had no significant differences in the 50% lethal dose, and one C. tropicalis isolate was less virulent than its companion C. albicans isolate. In contrast, in mice treated with antibiotics and cytarabine, an antineoplastic drug which damages the gastrointestinal mucosa and produces granulocytopenia, oral inoculation of yeast cells produced striking differences in the 50% infective dose: each C. tropicalis isolate was more virulent than the companion C. albicans isolate from the same institution. The increased virulence of the C. tropicalis isolates compared with the C. albicans isolates when given orally to compromised mice parallels clinical observations in compromised patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749689      PMCID: PMC347607          DOI: 10.1128/iai.37.2.833-836.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Infections in cancer patients.

Authors:  G P Bodey
Journal:  Cancer Treat Rev       Date:  1975-06       Impact factor: 12.111

2.  Alimentary tract colonization by Candida albicans.

Authors:  H H Stone; C E Geheber; L D Kolb; W R Kitchens
Journal:  J Surg Res       Date:  1973-04       Impact factor: 2.192

3.  Fungaemia and funguria after oral administration of Candida albicans.

Authors:  W Krause; H Matheis; K Wulf
Journal:  Lancet       Date:  1969-03-22       Impact factor: 79.321

4.  Studies in the pathogenesis, diagnosis, and treatment of Candida sepsis in children.

Authors:  H H Stone
Journal:  J Pediatr Surg       Date:  1974-02       Impact factor: 2.545

5.  Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study.

Authors:  E Z Ezdinli; D D O'Sullivan; L P Wasser; U Kim; L Stutzman
Journal:  JAMA       Date:  1979-07-20       Impact factor: 56.272

6.  Growth, morphogenesis, and virulence of Candida albicans after oral inoculation in the germ-free and conventional chick.

Authors:  E Balish; A W Phillips
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

7.  Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality.

Authors:  F Meunier-Carpentier; T E Kiehn; D Armstrong
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

8.  Candida tropicalis: a major pathogen in immunocompromised patients.

Authors:  J R Wingard; W G Merz; R Saral
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

9.  Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice.

Authors:  J R Wingard; J D Dick; W G Merz; G R Sandford; R Saral; W H Burns
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Gastrointestinal and disseminated candidiasis. An experimental model in the immunosuppressed rat.

Authors:  R L Myerowitz
Journal:  Arch Pathol Lab Med       Date:  1981-03       Impact factor: 5.534

View more
  21 in total

1.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.

Authors:  Karl V Clemons; Gloria M Gonzalez; Gaurav Singh; Jackie Imai; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Development of an integrative DNA transformation system for the yeast Candida tropicalis.

Authors:  L O Haas; J M Cregg; M A Gleeson
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

5.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.

Authors:  M J Kennedy; P A Volz
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Candida tropicalis infection in normal, diabetic, and neutropenic mice.

Authors:  R A Fromtling; G K Abruzzo; D M Giltinan
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 7.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Critical role of germ tube formation in the pathogenesis of candidal vaginitis.

Authors:  J D Sobel; G Muller; H R Buckley
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

9.  Characterization of Virulence-Related Phenotypes in Candida Species of the CUG Clade.

Authors:  Shelby J Priest; Michael C Lorenz
Journal:  Eukaryot Cell       Date:  2015-07-06

10.  Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.

Authors:  Karen Regina Carim da Costa; Joseane Cristina Ferreira; Marilena Chinali Komesu; Regina Celia Candido
Journal:  Mycopathologia       Date:  2008-09-12       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.